search
Back to results

Evaluation the Effects of Herbal Gargle for Chemoradiotherapy-induced Oral Mucositis of Head & Neck Cancer, a Pilot Study.

Primary Purpose

Head and Neck Neoplasms, Chemoradiotherapy, Stomatitis and Ulceration

Status
Not yet recruiting
Phase
Phase 2
Locations
Taiwan
Study Type
Interventional
Intervention
Herbal gargle
Normal saline
Sponsored by
Chang Gung Memorial Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Head and Neck Neoplasms focused on measuring Medicine, Chinese Traditional, Head and Neck Neoplasms, Chemoradiotherapy, Stomatitis and Ulceration

Eligibility Criteria

20 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Willing to join the trial project and sign the informed consent form.
  • Age more than 20 years-old.
  • Pathology proved to be head and neck cancers.
  • Head and neck cancer patients under radiotherapy or concurrent chemoradiotherapy.
  • Expected life expectancy more than 3 months.
  • Subjects with clear consciousness and can be assessed cooperatively.
  • Subjects are suitable to use Herbal gargle evaluated by Traditional Chinese medicine physicians.

Exclusion Criteria:

  • Subjects can not sing the informed consent form.
  • Systemic infection.
  • Heart, liver and kidney insufficiency
  • Allergy history of Traditional Chinese medicine
  • Unclear conscious to use Herbal gargle.

Sites / Locations

  • Keelung Chang Gung Memorial Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Sham Comparator

Arm Label

Treatment group

Control group

Arm Description

The treatment group receive Herbal gargle 150ml and are instructed to hold the gargle in the mouth for 30s and then expectorate it twice a day, 5 days a week for 8 weeks.

The control group receive Normal saline 150ml and are instructed to hold the normal saline in the mouth for 30s and then expectorate it twice a day, 5 days a week for 8 weeks.

Outcomes

Primary Outcome Measures

Change of CTCAE 4.0
CTCAE is used to describe the severity of oral mucositis for patients receiving cancer therapy.

Secondary Outcome Measures

Change of EORTC QLQ-C30
European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire score, EORTC QLQ-C30, is used to measure cancer patients' physical, psychological and social functions.
Change of EORTC QLQ-H&N35
European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-head & neck, EORTC QLQ-H&N35, is used for assessing the health-related quality of life for head-and-neck cancer patients.
Change of VAS of pain of oral mucositis
Visual Analogue Scale, VAS, is used to to measure the intensity of pain of oral mucositis.
Change of body weight
The oral mucositis caused by chemoradiotherapy will influence food intake. Monitor body weight provides objective evaluation of nutrition status.
Change of opioid use
Opioid analgesics is often prescribed for alleviating pain from oral mucositis. Monitor opioid use provides other evaluation for severity of pain and wound healing.
Change of albumin
Albumin has been used as maker of nutrition status.
Change of CRP
C-reactive protein is used to monitor severity of oral mucositis.
Change of common aerobic culture
Aerobic culture is used to monitor the change of bacteria flora before and after Herbal gargle treatment.

Full Information

First Posted
April 18, 2022
Last Updated
April 18, 2022
Sponsor
Chang Gung Memorial Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT05341206
Brief Title
Evaluation the Effects of Herbal Gargle for Chemoradiotherapy-induced Oral Mucositis of Head & Neck Cancer, a Pilot Study.
Official Title
Evaluation the Effects of Herbal Gargle for Chemoradiotherapy-induced Oral Mucositis of Head & Neck Cancer, a Pilot Study.
Study Type
Interventional

2. Study Status

Record Verification Date
April 2022
Overall Recruitment Status
Not yet recruiting
Study Start Date
April 15, 2022 (Anticipated)
Primary Completion Date
May 15, 2025 (Anticipated)
Study Completion Date
December 31, 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Chang Gung Memorial Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
The aim of the study is to evaluate the effects of Herbal gargle on chemoradiotherapy-induced stomatitis in head & neck cancer patients.
Detailed Description
Head and neck cancer accounts for about 5% of all cancers worldwide with the age-standardized incidence rate (ASIR) of HNC increased by 5.4% per year among males and 3.1% among females in Taiwan. Concurrent chemoradiotherapy (CCRT) is the most common management to treat head and neck cancer. However, CCRT may cause much side effects such as oral mucositis, radiation dermatitis, xerostomia, or infection, which influence food intake, disturb nutritional status and interrupt the course of treatment. Traditional Chinese Medicine (TCM) has been applied to treat cancer side effects for many years. Herbal gargle is composed of TCM herbals used for oral mucositis induced by chemoradiotherapy among head and neck cancer. The aim of the trial is to evaluate the effectiveness of Herbal gargle. The participants divide into two groups, treatment group and control group. The treatment group receive Herbal gargle 150ml and are instructed to hold the gargle in the mouth for 30s and then expectorate it twice a day, 5 days a week for 8 weeks. The control group receive normal saline 150ml for oral mucositis. The subjective questionnaires of EORTC QLQ-C30, EORTC QLQ-H&N35 are assessed twice a week, CTCAE for grading of oral mucositis is assessed once a week, VAS is assessed everyday for 8 weeks. Besides, change of opioid dosage, body weight are also recorded. The CRP is assessed before and every week for 8 weeks and the albumin and bacteria culture are assessed before and post-treatment of 4th week and 8th week. The baseline difference of treatment and control group will be analyzed by using independent t-test and the difference of evaluation scores and blood tests between pre-treatment and post-treatment will be analyzed using multivariate logistic regression analysis. A value of P < 0.05 will be regarded as statistically significant for the above statistical analyses.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Head and Neck Neoplasms, Chemoradiotherapy, Stomatitis and Ulceration
Keywords
Medicine, Chinese Traditional, Head and Neck Neoplasms, Chemoradiotherapy, Stomatitis and Ulceration

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Model Description
The treatment group receive Herbal gargle and control group receive normal saline.
Masking
None (Open Label)
Masking Description
The color of Herbal gargle is yellowish while normal saline is transparent. Therefore, the study belongs to open label trial.
Allocation
Randomized
Enrollment
80 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Treatment group
Arm Type
Experimental
Arm Description
The treatment group receive Herbal gargle 150ml and are instructed to hold the gargle in the mouth for 30s and then expectorate it twice a day, 5 days a week for 8 weeks.
Arm Title
Control group
Arm Type
Sham Comparator
Arm Description
The control group receive Normal saline 150ml and are instructed to hold the normal saline in the mouth for 30s and then expectorate it twice a day, 5 days a week for 8 weeks.
Intervention Type
Drug
Intervention Name(s)
Herbal gargle
Intervention Description
The treatment group receive Herbal gargle 150ml and are instructed to hold the gargle in the mouth for 30s and then expectorate it twice a day, 5 days a week for 8 weeks.
Intervention Type
Other
Intervention Name(s)
Normal saline
Intervention Description
The control group receive Normal saline 150ml and are instructed to hold the normal saline in the mouth for 30s and then expectorate it twice a day, 5 days a week for 8 weeks.
Primary Outcome Measure Information:
Title
Change of CTCAE 4.0
Description
CTCAE is used to describe the severity of oral mucositis for patients receiving cancer therapy.
Time Frame
change from baseline and every week for 8 weeks.
Secondary Outcome Measure Information:
Title
Change of EORTC QLQ-C30
Description
European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire score, EORTC QLQ-C30, is used to measure cancer patients' physical, psychological and social functions.
Time Frame
change from baseline at 4 weeks and 8 weeks post treatment.
Title
Change of EORTC QLQ-H&N35
Description
European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-head & neck, EORTC QLQ-H&N35, is used for assessing the health-related quality of life for head-and-neck cancer patients.
Time Frame
change from baseline at 4 weeks and 8 weeks post treatment.
Title
Change of VAS of pain of oral mucositis
Description
Visual Analogue Scale, VAS, is used to to measure the intensity of pain of oral mucositis.
Time Frame
change from baseline and everyday for 8 weeks.
Title
Change of body weight
Description
The oral mucositis caused by chemoradiotherapy will influence food intake. Monitor body weight provides objective evaluation of nutrition status.
Time Frame
change from baseline and every week for 8 weeks.
Title
Change of opioid use
Description
Opioid analgesics is often prescribed for alleviating pain from oral mucositis. Monitor opioid use provides other evaluation for severity of pain and wound healing.
Time Frame
change from baseline and every week for 8 weeks.
Title
Change of albumin
Description
Albumin has been used as maker of nutrition status.
Time Frame
change from baseline at 4 weeks and 8 weeks post treatment.
Title
Change of CRP
Description
C-reactive protein is used to monitor severity of oral mucositis.
Time Frame
change from baseline and every week for 8 weeks.
Title
Change of common aerobic culture
Description
Aerobic culture is used to monitor the change of bacteria flora before and after Herbal gargle treatment.
Time Frame
change from baseline and every week for 8 weeks.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
20 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Willing to join the trial project and sign the informed consent form. Age more than 20 years-old. Pathology proved to be head and neck cancers. Head and neck cancer patients under radiotherapy or concurrent chemoradiotherapy. Expected life expectancy more than 3 months. Subjects with clear consciousness and can be assessed cooperatively. Subjects are suitable to use Herbal gargle evaluated by Traditional Chinese medicine physicians. Exclusion Criteria: Subjects can not sing the informed consent form. Systemic infection. Heart, liver and kidney insufficiency Allergy history of Traditional Chinese medicine Unclear conscious to use Herbal gargle.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Yi-Hsine Shiao, Doctor
Phone
24313131
Ext
2777
Email
vincentking44@gmail.com
Facility Information:
Facility Name
Keelung Chang Gung Memorial Hospital
City
Keelung
State/Province
Keelung, Taiwan
ZIP/Postal Code
20401
Country
Taiwan
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Yi-Hsine Shiao, Doctor
Phone
24313131
Ext
2777
Email
vincentking44@gmail.com

12. IPD Sharing Statement

Learn more about this trial

Evaluation the Effects of Herbal Gargle for Chemoradiotherapy-induced Oral Mucositis of Head & Neck Cancer, a Pilot Study.

We'll reach out to this number within 24 hrs